{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:55:50Z","timestamp":1785700550738,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.trim.2026.102408","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:26:23Z","timestamp":1780327583000},"page":"102408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical outcomes of desensitization in intermediate-risk kidney transplant recipients: A dual-center study"],"prefix":"10.1016","volume":"97","author":[{"given":"Muhammad A.","family":"Bukhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab N.","family":"Habibullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monther","family":"Alazwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal E.","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutlaq","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhakim","family":"Almarwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2026.102408_bb0005","article-title":"Annual report for organ transplantation in Kingdom of Saudi Arabia","volume":"1","author":"Report","year":"2017","journal-title":"Saudi Cent. Organ Transplant. Annu. Rep."},{"issue":"10","key":"10.1016\/j.trim.2026.102408_bb0010","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1097\/TP.0000000000001650","article-title":"Long-term outcomes of kidney transplantation in patients with high levels of preformed DSA: the Necker high-risk transplant program","volume":"101","author":"Amrouche","year":"2017","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.trim.2026.102408_bb0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.trim.2015.01.002","article-title":"Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation","volume":"32","author":"Malheiro","year":"2015","journal-title":"Transpl. Immunol."},{"issue":"8381","key":"10.1016\/j.trim.2026.102408_bb0020","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(84)92273-6","article-title":"Renal transplantation after removal and prevention of Resynthesis of Hla antibodies","volume":"323","author":"Taube","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2026.102408_bb0025","first-page":"1","article-title":"Current approaches to desensitization in solid organ transplantation","volume":"12","author":"Schinstock","year":"2021"},{"issue":"6","key":"10.1016\/j.trim.2026.102408_bb0030","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/TP.0b013e3182802f88","article-title":"Efficacy, outcomes, and cost-effectiveness of desensitization using ivig and rituximab","volume":"95","author":"Vo","year":"2013","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.trim.2026.102408_bb0035","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1097\/TP.0000000000001619","article-title":"Kidney transplant with low levels of DSA or low positive B-flow crossmatch: an underappreciated option for highly sensitized transplant candidates","volume":"101","author":"Schinstock","year":"2017","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.trim.2026.102408_bb0040","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.trim.2026.102408_bb0045","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ajt.12786","article-title":"Quantifying the risk of incompatible kidney transplantation: a multicenter study","volume":"14","author":"Orandi","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2026.102408_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11936-015-0431-9","article-title":"Desensitization strategies pre- and post-cardiac transplantation","volume":"18","author":"Cole","year":"2016","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"10.1016\/j.trim.2026.102408_bb0055","doi-asserted-by":"crossref","unstructured":"Sethi S, Choi J, Toyoda M, Vo A, Peng A, Jordan SC. Desensitization: overcoming the immunologic barriers to transplantation. 2017;.","DOI":"10.1155\/2017\/6804678"},{"issue":"6","key":"10.1016\/j.trim.2026.102408_bb0060","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.4103\/1319-2442.248311","article-title":"The National Guard Health Affairs guidelines for the medical management of renal transplant patients","volume":"29","author":"Arabi","year":"2018","journal-title":"Saudi J. Kidney Dis. Transpl."},{"issue":"5","key":"10.1016\/j.trim.2026.102408_bb0065","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-6143.2009.02577.x","article-title":"Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss","volume":"9","author":"Everly","year":"2009","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.trim.2026.102408_bb0070","article-title":"Long-term outcomes of kidney transplantation in patients with high levels of preformed DSA: the Necker high-risk transplant program","volume":"101","author":"Amrouche","year":"2017"},{"key":"10.1016\/j.trim.2026.102408_bb0075","doi-asserted-by":"crossref","unstructured":"Loupy A, Lefaucheur, Vernerey D, Prugger C, et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. 2013;1215\u201326.","DOI":"10.1056\/NEJMoa1302506"},{"issue":"12","key":"10.1016\/j.trim.2026.102408_bb0080","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1432-2277.2008.00755.x","article-title":"Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation","volume":"21","author":"Li","year":"2008","journal-title":"Transpl. Int."},{"issue":"9","key":"10.1016\/j.trim.2026.102408_bb0085","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1681\/ASN.2004121130","article-title":"Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation","volume":"16","author":"Hourmant","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.trim.2026.102408_bb0090","first-page":"443","article-title":"Analysis of predictive and preventive factors for de novo DSA in kidney transplant recipients","volume":"98","author":"Hirai","year":"2014"},{"issue":"6","key":"10.1016\/j.trim.2026.102408_bb0095","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.humimm.2018.02.014","article-title":"Impact of persistent and cleared preformed HLA DSA on kidney transplant outcomes","volume":"79","author":"Redondo-Pach\u00f3n","year":"2018","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2026.102408_bb0100","first-page":"494","article-title":"Desensitization in kidney transplantation\u202f: review and future perspectives","volume":"8","author":"Bg","year":"2014"},{"issue":"7","key":"10.1016\/j.trim.2026.102408_bb0105","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.TP.0000437671.78716.f3","article-title":"Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximab","volume":"97","author":"Barbosa","year":"2014","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.trim.2026.102408_bb0110","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/tid.12465","article-title":"JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximab","volume":"17","author":"Toyoda","year":"2015","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2026.102408_bb0115","doi-asserted-by":"crossref","unstructured":"Dekeyser M, Taupin J, Elias M, Icha\u00ef P, Herr F, Boudon M, et al. Impact of DSA and immunosuppression minimization on rejection, graft, and patient survival after simultaneous liver \u2013 kidney transplantation. 2022:1\u201313.","DOI":"10.3389\/fmed.2022.949833"},{"key":"10.1016\/j.trim.2026.102408_bb0120","doi-asserted-by":"crossref","unstructured":"Guo Z, Zhao D, Sa R, Wang L. A modi fi ed perioperative regimen for deceased donor kidney transplantation in presensitized recipients without prior desensitization therapy. 2023:1\u201311.","DOI":"10.3389\/fimmu.2023.1223567"},{"key":"10.1016\/j.trim.2026.102408_bb0125","series-title":"Outcomes of kidney transplantation in highly HLA-sensitized patients treated with intravenous immuno-globulin, plasmapheresis and rituximab\u202f: a meta-analysis","author":"Chandramohan","year":"2024"},{"issue":"2","key":"10.1016\/j.trim.2026.102408_bb0130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody","volume":"6","author":"Stegall","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2026.102408_bb0135","doi-asserted-by":"crossref","unstructured":"Green H, Nesher E, Aizner S, Israeli M, Klein T, Zakai H, et al. Long - term results of desensitization protocol with and without rituximab in sensitized kidney transplant recipients. 2019:1\u201313.","DOI":"10.1111\/ctr.13562"},{"key":"10.1016\/j.trim.2026.102408_bb0140","first-page":"373","article-title":"Desensitization protocols improving access and outcome in transplantation","volume":"5","author":"Zachary","year":"2005"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:39:40Z","timestamp":1785699580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327426000663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"alternative-id":["S0966327426000663"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2026.102408","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of desensitization in intermediate-risk kidney transplant recipients: A dual-center study","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2026.102408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102408"}}